ID   USF-MC1
AC   CVCL_E7Y5
SY   University of South Florida-Mast Cell line 1
RX   DOI=10.1016/j.jaci.2008.12.750;
RX   Patent=US9096829;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/14886-Human-Mast-Cell-Line-and-Uses-Thereof.html
CC   Group: Patented cell line.
CC   Doubling time: 1-2 weeks (Patent=US9096829).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   DOI=10.1016/j.jaci.2008.12.750;
RA   Glaum M.C., Liu G.-Q., Lockey R.F., Mohapatra S.S.;
RT   "Mediator release from a new human mast cell line (USF-MC1).";
RL   J. Allergy Clin. Immunol. 123 Suppl. 2:S197.757-S197.757(2009).
//
RX   Patent=US9096829;
RA   Mohapatra S.S., Glaum M.C., Liu G.-Q.;
RT   "Human mast cell line and uses thereof.";
RL   Patent number US9096829, 04-Aug-2015.
//